Vedolizumab Doesn ' t Increase Risk of C diff in Ulcerative Colitis Vedolizumab Doesn ' t Increase Risk of C diff in Ulcerative Colitis

Vedolizumab ' s effects in the intestines have led to concerns that the antibody could increase the risk of C difficile infection in patients with ulcerative colitis.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news